Status:
UNKNOWN
Predictors of Sorafenib Response in HCC
Lead Sponsor:
Sohag University
Conditions:
Hepatocellular Carcinoma
Eligibility:
All Genders
Brief Summary
Evaluating the nutrition status of patients with advanced HCC who received sorafenib. Using the pretreatment nutrition status and quality of life as predictors to sorafenib response
Detailed Description
This a cross sectional study will be conducted on 100 HCC treated with sorafenib Data were gathered from medical records, including age sex body weight and height (BMI) pre-therapy laboratory counts ...
Eligibility Criteria
Inclusion
- HCC recieved sorafenib
Exclusion
- Patient refuse to participate
- Patients recieving other treatment modalities
Key Trial Info
Start Date :
August 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2024
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT05967429
Start Date
August 1 2023
End Date
June 1 2024
Last Update
August 1 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.